Literature DB >> 24551286

Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration.

Zhong-Yuan Wan1, Zhen Sun1, Fang Song2, Yu-Fei Chen1, Wei-Lin Zhang1, Hai-Qiang Wang1, Zhuo-Jing Luo1.   

Abstract

Interleukin 37 (IL-37) is an anti-inflammatory cytokine which was proven to be associated with several diseases characterized with excessive-inflammation. The pathologic process of Intervertebral disc degeneration (IVDD) is also companied by uncurbed inflammation, many cytokines were reported presenting in the process. However, there is little IL-37 related knowledge in IVDD up to now. The aim of this study was to investigate whether IL-37 expression in degenerative intervertebral disc (IVD) is different from that in non-degenerative disc and to evaluate the relationship between IL-37 expression, overexpression of pro-inflammatory cytokines and development of degeneration. Human nucleus pulposus samples were obtained from patients with disc degenerative disease and vertebra fractures undergoing discectomy and fusion. Subsequently, expression of IL-37 was assessed by real-time quantitative polymerase chain reaction (RT-PCR) and western blotting. Gene expression level was measured for IL-1α, IL-1β, IL-6, IL-16, TNF-α, TGF-β1 and Smad3. Degree of degeneration was evaluated for MRI with modified Pfirrmann grading system. The results showed that IL-37 had a decreased expression in degenerative samples compared to that in normal samples both at mRNA and protein level. Instead, significant elevated gene expression of IL-1β, IL-16, TNF-α, TGF-β1 and Smad3 were detected in degenerative samples. High correlations were observed between IL-37, IL-1β, IL-16, TGF-β1, Smad3 and degeneration degree of IVD. Downregulation of IL-37 expression appeared to result in overexpression of pro-inflammatory cytokines, such as IL-1β and IL-16, in degenerative IVD and may be a contributor involved in the progression of IVDD.

Entities:  

Keywords:  Intervertebral disc degeneration; anti-inflammatory cytokine; interleukin 16; interleukin 37; interleukin-1 beta

Mesh:

Substances:

Year:  2014        PMID: 24551286      PMCID: PMC3925910     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Identification and initial characterization of four novel members of the interleukin-1 family.

Authors:  S Kumar; P C McDonnell; R Lehr; L Tierney; M N Tzimas; D E Griswold; E A Capper; R Tal-Singer; G I Wells; M L Doyle; P R Young
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

3.  Interleukin-37 is elevated in subjects with atopic dermatitis.

Authors:  Hiroyuki Fujita; Yusuke Inoue; Katsuya Seto; Noriko Komitsu; Michiko Aihara
Journal:  J Dermatol Sci       Date:  2012-11-10       Impact factor: 4.563

Review 4.  Interleukin-16.

Authors:  W W Cruikshank; H Kornfeld; D M Center
Journal:  J Leukoc Biol       Date:  2000-06       Impact factor: 4.962

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Interleukin-16 network in inflammation and allergy.

Authors:  Pio Conti; Duraisamy Kempuraj; Kristiana Kandere; Mario Di Gioacchino; Marcella Reale; Renato C Barbacane; Maria L Castellani; Umberto Mortari; William Boucher; Richard Letourneau; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2002 Mar-Apr       Impact factor: 2.587

7.  Epithelial expression of interleukin-37b in inflammatory bowel disease.

Authors:  H Imaeda; K Takahashi; T Fujimoto; E Kasumi; H Ban; S Bamba; H Sonoda; T Shimizu; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

8.  Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Authors:  Sanjay Kumar; Charles R Hanning; Michael R Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John C Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Journal:  Cytokine       Date:  2002-04-21       Impact factor: 3.861

Review 9.  Cell therapy for disc degeneration--potentials and pitfalls.

Authors:  Helena Brisby; Helen Tao; David D F Ma; Ashish D Diwan
Journal:  Orthop Clin North Am       Date:  2004-01       Impact factor: 2.472

10.  Interleukin 1 polymorphisms and intervertebral disc degeneration.

Authors:  Svetlana Solovieva; Sanna Kouhia; Päivi Leino-Arjas; Leena Ala-Kokko; Katariina Luoma; Raili Raininko; Janna Saarela; Hilkka Riihimäki
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

View more
  8 in total

1.  Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.

Authors:  Lijuan Wang; Yanchun Quan; Yongfang Yue; Xueyuan Heng; Fengyuan Che
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 2.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

3.  TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Ye Tian; Wen Yuan; Jun Li; Hua Wang; Maxwell G Hunt; Chao Liu; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2015-11-27       Impact factor: 11.583

4.  Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells.

Authors:  Sen Wang; Weifang An; Yunhong Yao; Renhuai Chen; Xiaoxuan Zheng; Wanyong Yang; Yi Zhao; Xinrong Hu; Enping Jiang; Yanhong Bie; Zhangquan Chen; Ping Ouyang; He Zhang; Hui Xiong
Journal:  J Cancer       Date:  2015-08-08       Impact factor: 4.207

5.  Plasma Interleukin-37 Is Elevated in Patients with Rheumatoid Arthritis: Its Correlation with Disease Activity and Th1/Th2/Th17-Related Cytokines.

Authors:  Ting Xia; Xing-feng Zheng; Bao-hua Qian; He Fang; Jun-jie Wang; Lan-ling Zhang; Ya-fei Pang; Ju Zhang; Xiao-qing Wei; Zhao-fan Xia; Dong-bao Zhao
Journal:  Dis Markers       Date:  2015-09-06       Impact factor: 3.434

6.  Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages.

Authors:  Seong-Kyu Kim; Jung-Yoon Choe; Ki-Yeun Park
Journal:  Yonsei Med J       Date:  2021-11       Impact factor: 2.759

7.  Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.

Authors:  Yanqun Li; Zi Wang; Ting Yu; Bingni Chen; Jinshun Zhang; Kunzhao Huang; Zhong Huang
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

8.  Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression.

Authors:  Jifeng Zhu; Chuanjiang Xie; Hongjiu Qiu; Ling Shi
Journal:  Int J Gen Med       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.